SCHEMBL2301329

SCHEMBL2301329

Clc1cccc(OC2C[N]C2)c1Cl

nearest known ligand 0.42

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 12/20 0.42
SLC6A4 P31645 10/20 0.42
SLC6A3 Q01959 9/20 0.42
HTR1A P08908 5/20 0.42
ALDH1A1 P00352 2/20 0.39
RHEB Q15382 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.37
KCNH2 Q12809 2/20 0.36
KDM4E B2RXH2 1/20 0.35
CYP2D6 P10635 2/20 0.35
SCD O00767 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2300974 0.85 SLC6A4 (0.54) SLC6A2SLC6A4SLC6A3HTR1ASMN1; SMN2
SCHEMBL3129196 0.82 SLC6A4 (0.41) SLC6A2SLC6A4SLC6A3HTR1AALDH1A1
SCHEMBL2301991 0.79 HTR1A (0.41) SLC6A2SLC6A4SLC6A3HTR1AKCNH2
SCHEMBL14957210 0.78 SLC6A2 (0.64) SLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL9913885 0.76 SLC6A2 (0.46) SLC6A2SLC6A4SLC6A3HTR1AALDH1A1
SCHEMBL9913817 0.76 SLC6A2 (0.46) SLC6A2SLC6A4SLC6A3HTR1AALDH1A1
SCHEMBL15477138 0.76 SLC6A2 (0.46) SLC6A2SLC6A4SLC6A3HTR1AALDH1A1
SCHEMBL3080032 0.75 SLC6A2 (0.57) SLC6A2SLC6A4SLC6A3HTR1AKCNH2
Hydrochloric Acid SCHEMBL9275471 0.75 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3HTR1AALDH1A1
Hydrochloric Acid SCHEMBL9275475 0.75 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3HTR1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2536689-A1 ARYL CARBOXAMIDE DERIVATIVES AS SODIUM CHANNEL INHIBITORS FOR TREATMENT OF PAIN Amgen Inc. (US) 2012-12-26 EP disclosed
WO-2011103196-A1 ARYL CARBOXAMIDE DERIVATIVES AS SODIUM CHANNEL INHIBITORS FOR TREATMENT OF PAIN AMGEN INC. (US) 2011-08-25 WO disclosed